Rhythm PharmaceuticalsvsUnitedHealth

RYTM and UNH stock compared: price, dividend, valuation and results, from SEC filings.

RYTM

Rhythm Pharmaceuticals, Inc.

$119.04

Value $8.1B

+2.08%
RYTM's page

UNH

UnitedHealth Group Incorporated

$349.91

Value $318B

-10.21%
UNH's page

Rhythm Pharmaceuticals (RYTM) has a market value of $8.1B and UnitedHealth (UNH) $318B. Over the last year, with dividends, RYTM moved +18.2% and UNH +12.1%. Dividend yield: RYTM none, UNH 2.59%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    RYTM$8.1B

    UNH$318B

    UNH is 39 times RYTM

  • Revenue, 12 months

    RYTM$281M

    UNH$450B

    UNH is 1,602 times RYTM

  • Net income, 12 months

    RYTM-$194M

    UNH$15.9B

  • Operating margin

    RYTM-66.7%

    UNH5.3%

    72.0 points apart

  • ROIC

    RYTM-65.1%

    UNH11.3%

    76.4 points apart

  • P/E

    RYTM–

    UNH20.0

  • Dividend yield

    RYTM0.0%

    UNH2.6%

    2.6 points apart

  • 5-year return

    RYTM+892.0%

    UNH-14.7%

    906.7 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

RYTM+892.0%

UNH-14.7%

0500100020222023202420252026
Returns by period
PeriodRYTMWith dividendsUNHWith dividends
1 year since November 17, 2025+18.2%Price +18.2%+12.1%Price +9.2%
3 years since November 17, 2023+252.0%+52.1% a yearPrice +252.0%-30.5%-11.4% a yearPrice -34.8%
5 years since November 17, 2021+892.0%+58.2% a yearPrice +892.0%-14.7%-3.1% a yearPrice -22.1%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

RYTMRhythm PharmaceuticalsUNHUnitedHealth

Valuation

RYTMUNH
Valuation
Price$119.04$349.91
Market value$8.1B$318B
Enterprise value (EV)–$363B
P/E–20.0
P/E, 5-year median–25.0
P/B92.43.1
EV/EBIT–15.2
Free cash flow yield–7.2%

Results and growth

RYTMUNH
Results and growth
Revenue, 12 months$281M$450B
Net income, 12 months-$194M$15.9B
Free cash flow, 12 months-$83M$22.8B
Earnings per share, 12 months-$2.90$17.52
Revenue growth, year on year45.8%11.8%
Revenue growth a year, past–+11.7%over 5 years
EPS growth a year, past–-3.8%over 5 years

Margins and returns on capital

RYTMUNH
Margins and returns on capital
Gross margin88.2%88.3%
Operating margin-66.7%5.3%
Net margin-69.0%3.5%
ROIC-65.1%11.3%
ROE-161.0%15.5%

Balance sheet

RYTMUNH
Balance sheet
Cash$321M$28.5B
Total debt–$74.3B
Net debt / EBITDA–1.6
Interest cover-10.3×6.2×

Dividends and buybacks

RYTMUNH
Dividends and buybacks
Dividend yield–2.6%
Dividend per share, 12 months–$9.06
Dividend growth a year, past–+12.6%over 5 years
Buyback yield–1.8%
Shareholder yield–4.3%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: RYTM or UNH

Didn't find what you were looking for?

Ask us
Which is bigger, Rhythm Pharmaceuticals or UnitedHealth?

By market value, UnitedHealth ($318B) is about 39.1 times Rhythm Pharmaceuticals ($8.1B), at today's prices.

How did RYTM and UNH stock do over the last 5 years?

Since November 17, 2021, RYTM's price moved +892.0% and UNH's -22.1%. With dividends: RYTM +892.0% (+58.2% a year), UNH -14.7% (-3.1% a year). Past returns do not predict future ones.

Which pays the higher dividend, RYTM or UNH?

The dividend yield at today's price is none for Rhythm Pharmaceuticals and 2.59% for UnitedHealth. Over the last twelve months they paid – and $9.06 per share.

Which has the higher profit margins, Rhythm Pharmaceuticals or UnitedHealth?

Over the last twelve months, the net margin was -69.0% for Rhythm Pharmaceuticals and 3.5% for UnitedHealth, and the operating margin -66.7% and 5.3%. Revenue was $281M and $450B.

Which is the better investment, Rhythm Pharmaceuticals or UnitedHealth?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.